Triple
T839865
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Phillip A. Sharp |
E18151
|
entity |
| Predicate | coFounded |
P104
|
FINISHED |
| Object |
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
|
E100609
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Alnylam Pharmaceuticals | Statement: [Phillip A. Sharp, coFounded, Alnylam Pharmaceuticals]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Alnylam Pharmaceuticals Context triple: [Phillip A. Sharp, coFounded, Alnylam Pharmaceuticals]
-
A.
Ionis Pharmaceuticals
Ionis Pharmaceuticals is a biotechnology company specializing in the discovery and development of RNA-targeted therapeutics using antisense technology.
-
B.
Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
-
C.
Gilead Sciences (board member)
Gilead Sciences is a major American biopharmaceutical company known for developing antiviral drugs, including treatments for HIV, hepatitis C, and other serious diseases.
-
D.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
E.
Danaher Corporation
Danaher Corporation is a diversified global science and technology conglomerate known for its portfolio of life sciences, diagnostics, and industrial solutions businesses.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Alnylam Pharmaceuticals Triple: [Phillip A. Sharp, coFounded, Alnylam Pharmaceuticals]
Generated description
Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Alnylam Pharmaceuticals Target entity description: Alnylam Pharmaceuticals is a biopharmaceutical company specializing in the development of RNA interference (RNAi)-based therapeutics for genetically defined diseases.
-
A.
Ionis Pharmaceuticals
Ionis Pharmaceuticals is a biotechnology company specializing in the discovery and development of RNA-targeted therapeutics using antisense technology.
-
B.
Biogen
Biogen is a major American biotechnology company known for developing therapies for neurological and neurodegenerative diseases.
-
C.
Gilead Sciences (board member)
Gilead Sciences is a major American biopharmaceutical company known for developing antiviral drugs, including treatments for HIV, hepatitis C, and other serious diseases.
-
D.
Genentech
Genentech is a pioneering American biotechnology company known for developing groundbreaking therapies and being one of the first firms to apply genetic engineering to medicine.
-
E.
Danaher Corporation
Danaher Corporation is a diversified global science and technology conglomerate known for its portfolio of life sciences, diagnostics, and industrial solutions businesses.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a49389f44881909a608fb27d89f247 |
completed | March 1, 2026, 7:29 p.m. |
| NER | Named-entity recognition | batch_69a4abe4ab1081909207ae2eec1898d9 |
completed | March 1, 2026, 9:13 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a7929860f081909c86f84d7cfe6acb |
completed | March 4, 2026, 2:02 a.m. |
| NEDg | Description generation | batch_69a796370f388190b23cd19cc3fa5a3b |
completed | March 4, 2026, 2:17 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69a796bee5388190ab0abf0bfa08ad97 |
completed | March 4, 2026, 2:19 a.m. |
Created at: March 1, 2026, 7:38 p.m.